Psychedelics

One researcher shares his evidence for the usage of psilocybin in psychiatry.

We have an urgent need for new and improved treatment options for depression—are psychedelic medications the answer?

Treatments alter the neural processes underlying SAD symptoms.

How can psychedelic research incorporate disability inclusion into future work?

What are your thoughts on psychedelics?

Drug comparison has significant implications for dose- and substance-dependence.

Welcome to the psychedelic renaissance.

Psychedelics: returning hope to veterans with PTSD.

What does the movie Dune say about our society’s current relationship with psychedelics?

A kappa-opioid receptor with psychedelic effects, this potential agent for treatment-resistant depression and other disorders will be paired with a digital therapeutic for maximum efficacy.

Early studies find psilocybin shows promise for some psychiatric disorders...

New research is being conducted on how psychedelic substances may change the future of mental health care. Dr Carlin explained more in her speech at the Annual Psychiatric Times® World CME Conference™.

An exploration of findings from contemporary research that hint at the unexplored hallucinogenic potential of ketamine and considerations for future investigation.

Here: a review of the scientific evidence relevant to the use of classic hallucinogens in the treatment of substance use disorders.